1.
Seven-year follow-up of infliximab therapy in rheumatoid arthritis patients with severe long-standing refractory disease : attrition rate and evolution of disease activity.
2.
3.
4.
5.
AB0425 Real-world effectiveness of Filgotinib in belgian patients with rheumatoid arthritis
FRI0668 FIRST DATA OF THE TARDIS-RAREGISTRY, A NATIONWIDE BELGIAN BIOLOGIC REGISTRY
Improvements in productivity and increased participation in daily activities over 52 weeks of certolizumab pegol treatment of rheumatoid arthritis: results of a Belgian observation...
The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: clues for the optimization of rituximab treatment strategies
6.
7.
The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry : clues for the optimization of rituximab treatment strategies.
8.
9.
POS0694 What treatment gives the best clinical response after cessation of JAKi therapy in patients with RA? data of the TARDIS-RA registry, a nationwide belgian biologic registry
High prevalence of occupational exposure to solvents or silica in male systemic sclerosis patients: a Belgian cohort analysis
A general practice perspective on early rheumatoid arthritis management: A qualitative study from Flanders
Up to 5-year retention of abatacept in Belgian patients with moderate-to-severe rheumatoid arthritis: a sub-analysis of the international, observational ACTION study